Very recent findings have indicated that the population of PD-1/PD-L1-expressing tumor cells is resistant to anti-PD-1/PD-L1 immunotherapy [39], and PD-1-expressing tumor cells block neutrophil cytotoxicity in cancer [45]. Here, PDCD1 is linked to cancer.